BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright ©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Mar 20, 2026; 16(1): 109784
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.109784
Innovative prospects in 3D printed bio-scaffolds for osteochondral tissue engineering: A systematic review
Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Shrideavi Murugan, Sathish Muthu
Madhan Jeyaraman, Naveen Jeyaraman, Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India
Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Sathish Muthu, Department of Regenerative Medicine, Agathisha Institute of Stemcell and Regenerative Medicine, Chennai 600030, Tamil Nadu, India
Madhan Jeyaraman, Naveen Jeyaraman, Sathish Muthu, Department of Orthopaedics, Orthopaedic Research Group, Coimbatore 641045, Tamil Nadu, India
Arulkumar Nallakumarasamy, Department of Orthopaedics, Jawaharlal Institute of Postgraduate Medical Education and Research, Karaikal 609602, Puducherry, India
Shrideavi Murugan, Department of Orthopaedics, Government Tirunelveli Medical College and Hospital, Tirunelveli 627002, Tamil Nadu, India
Author contributions: Jeyaraman M and Nallakumarasamy A contributed to conceptualization; Jeyaraman N contributed to acquiring clinical data and performing the data analysis; Jeyaraman M, Jeyaraman N, Nallakumarasamy A and Muthu S contributed to manuscript writing; Murugan S helped in manuscript revision; Jeyaraman N contributed to proofreading; Jeyaraman M contributed to administration; all authors have agreed to the final version to be published and agree to be accountable for all aspects of the work.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Madhan Jeyaraman, MD, PhD, Researcher, Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Velappanchavadi, Chennai 600077, Tamil Nadu, India. madhanjeyaraman@gmail.com
Received: May 21, 2025
Revised: June 28, 2025
Accepted: October 13, 2025
Published online: March 20, 2026
Processing time: 265 Days and 6.3 Hours
Abstract
BACKGROUND

Advancements in 3D printing technologies have significantly transformed osteochondral tissue engineering, enabling the creation of scaffolds that closely mimic the structural and biological complexities of native tissue. These scaffolds provide a 3D environment conducive to cellular adhesion, proliferation, and differentiation while maintaining critical mechanical and biodegradable properties.

AIM

To explore the feasibility of 3D printed scaffolds in osteochondral applications, highlights innovative materials and techniques, and addresses the existing knowledge gaps and challenges in clinical translation.

METHODS

This scoping review adhered to PRISMA extension for scoping reviews guidelines to systematically map innovations in 3D printed bio-scaffolds for osteochondral tissue engineering. Due to heterogeneous data, it favored a scoping over systematic or meta-analytic approaches. The review aimed to identify innovations in scaffold materials, fabrication techniques, and translational strategies. Key questions addressed bioprinting methods, scaffold designs, and translational challenges. Studies included were in English, peer-reviewed, and focused on 3D printed scaffolds for osteochondral repair. Exclusions were non-osteochondral, non-3D fabrication studies, grey literature, editorials, and non-English papers. Literature was sourced from six databases using comprehensive keywords and Boolean operators. Backward citation tracking added relevant studies; no date limits were applied. Screening followed a four-phase selection process with dual independent reviewers. Data were charted thematically without bias assessment, focusing on methods, outcomes, and future gaps.

RESULTS

The fabrication of biomimetic scaffolds, incorporating bioactive elements such as growth factors, has shown promise in replicating the extracellular matrix and enhancing tissue regeneration. Cutting-edge techniques, including inkjet, extrusion-based, and laser-assisted bioprinting, allow precise spatial control and multi-material integration essential for osteochondral scaffolds. Innovations such as graded scaffolds and bio-inks enriched with nanoparticles have further improved scaffold functionality, mechanical stability, and biological activity. Despite these advancements, limitations persist, including material challenges in achieving the desired balance of bioactivity, biodegradability, and mechanical properties. Fabrication methods face issues of scalability, reproducibility, and resolution, while the long-term biological interactions between scaffolds and host tissues, particularly degradation products, remain underexplored. Regulatory and economic barriers also impede clinical translation, underscoring the need for collaborative research efforts. Future directions emphasize the potential of emerging technologies, such as 4D printing, smart biomaterials, and soundwave patterning, to address current challenges and unlock new opportunities.

CONCLUSION

The convergence of biomaterial science, additive manufacturing, and regenerative medicine holds immense promise for advancing personalized treatments and revolutionizing osteochondral tissue engineering.

Keywords: 3D printing; Tissue engineers; Osteochondral tissue engineering; Extracellular matrix; Cartilage

Core Tip: Advancements in 3D printing have revolutionized osteochondral tissue engineering by enabling biomimetic scaffolds that replicate native tissue complexities. These scaffolds support cellular adhesion, proliferation, and differentiation while maintaining mechanical integrity and biodegradability. Innovative techniques, such as laser-assisted bioprinting and bio-inks enriched with nanoparticles, enhance functionality and regeneration. However, challenges persist in scalability, reproducibility, and clinical translation. Future directions, including 4D printing and smart biomaterials, offer promising solutions for personalized treatments.